Non-drug evidence map · Sleep and circadian approaches

Sleep and circadian interventions

213 registered trials across 40 conditions, from ClinicalTrials.gov.

  1. Research Tracker
  2. Non-drug evidence map
  3. Sleep and circadian interventions

Approaches that target sleep quality or timing, other than medicines. This page lists the registered trials that test it, condition by condition, with each trial's status on ClinicalTrials.gov.

213registered trials
40conditions
88completed
23with results posted
62recruiting as of 2026-11-16
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Trials by condition

Sorted by number of trials. Within a condition, trials with posted results come first, then completed, recruiting and active ones. The condition name opens its evidence-gap map.

ConditionTrialsCompletedResults postedRecruitingRandomisedLargest trial (participants)
Insomnia
Show trials
6520 1026 5017,000
Obstructive Sleep Apnea
Show trials
5927 713 271,836
Type 1 Diabetes Mellitus
Show trials
114 26 8300
Attention Deficit-Hyperactivity Disorder
Show trials
104 23 7100
Obesity
Show trials
104 13 9328
Bipolar Disorder
Show trials
83 01 5170
Epilepsy
Show trials
73 12 5320
Asthma
Show trials
64 00 283
Major Depressive Disorder
Show trials
65 00 3208
Type 2 Diabetes Mellitus
Show trials
61 03 4400
Migraine Disorder
Show trials
54 01 180
Pulmonary Arterial Hypertension
Show trials
42 00 260
Chronic Obstructive Pulmonary Disease
Show trials
32 20 2400
Fibromyalgia
Show trials
32 01 2390
HIV/AIDS
Show trials
30 01 2400
Multiple Sclerosis
Show trials
31 01 390
Parkinson Disease
Show trials
31 01 2136
Restless Legs Syndrome
Show trials
33 00 21,260
Schizophrenia
Show trials
30 02 2140
Heart Failure
Show trials
22 00 128
Inflammatory Bowel Disease
Show trials
20 02 0216
Osteoarthritis
Show trials
21 11 2600
Alcohol Abuse
Show trials
11 00 1141
Alzheimer's Disease and Other Dementias
Show trials
10 00 0100
Amyotrophic Lateral Sclerosis
Show trials
10 00 125
Anxiety
Show trials
10 01 056
Atopic Eczema
Show trials
10 00 016
Breast Cancer
Show trials
10 00 1747
Cancer
Show trials
10 00 046
Diabetic Neuropathy
Show trials
10 00 00
Glaucoma
Show trials
11 00 0–
Gulf War Illness
Show trials
11 00 1118
Huntington Disease
Show trials
10 00 112
Irritable Bowel Syndrome
Show trials
11 00 125
Ischemic Stroke
Show trials
10 01 1200
Low Back Pain
Show trials
11 00 1106
Opioid Use Disorder
Show trials
10 00 10
Prostate Cancer
Show trials
10 01 140
Rheumatoid Arthritis
Show trials
11 00 013
Sarcopenia
Show trials
11 00 128

What these trials measure

Primary outcomes, grouped by keyword rules: Sleep (131), Symptom severity and disease activity (62), Feasibility, adherence and safety (43), Mood, anxiety and wellbeing (22), Weight and metabolic markers (16), Breathing and lung function (11), Quality of life (11), Inflammation and other biomarkers (10), Pain (10), Physical function and exercise capacity (9), Heart rate, blood pressure and autonomic (7), Cognition (7), Fatigue and energy (3), Clinical events, survival and healthcare use (2).

Names used for this class in the registry

sleep extension, sleep intervention, brief behavioral treatment for insomnia (bbti), brief behavioral therapy for insomnia (bbti), brief behavioral therapy for insomnia, sleep hygiene, home sleep apnea test, sleep course, sleepiz one+, triple chronotherapy, sleep hygiene training, apnea and insomnia relief (air)

Download all 213 trials (CSV) All non-drug classes

Related in Sleep and circadian approaches: Positive airway pressure and oral appliances

Source: ClinicalTrials.gov, searched 2026-11-16. Classification rules and exclusions: how this map is built.